{"filing":{"accession_number":"0001213900-26-072645","cik":"0000803578","ticker":"AIFF","company_name":"FIREFLY NEUROSCIENCE, INC.","form":"8-K","filing_date":"2026-06-26","report_date":null,"primary_document":"ea0295878-8k_firefly.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/803578/000121390026072645/ea0295878-8k_firefly.htm"},"events":[{"id":14279,"run_id":12703,"accession_number":"0001213900-26-072645","anchor_item_number":"1.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"summary":"The filing discloses termination of a securities purchase agreement for a $1,000,000 private placement of 666,667 units at $1.50 per unit. While the termination itself is the stated Item 1.02 event, the material substance is the failure of a planned dilutive equity issuance that would have raised significant capital. For a small-cap company like Firefly Neuroscience, the loss of this $1M financing is material to investor assessment of liquidity and capital structure, even though the agreement was terminated rather than completed.","company_name":"FIREFLY NEUROSCIENCE, INC.","ticker":"AIFF","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":[{"id":11655,"accession_number":"0001213900-26-072645","item_number":"1.02","item_title":"Termination of a Material Definitive","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"The filing discloses termination of a securities purchase agreement for a $1,000,000 private placement of 666,667 units at $1.50 per unit. While the termination itself is the stated Item 1.02 event, the material substance is the failure of a planned dilutive equity issuance that would have raised significant capital. For a small-cap company like Firefly Neuroscience, the loss of this $1M financing is material to investor assessment of liquidity and capital structure, even though the agreement was terminated rather than completed.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:31:44.844384+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11655,"accession_number":"0001213900-26-072645","item_number":"1.02","item_title":"Termination of a Material Definitive","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.72,"reasoning":"The filing discloses termination of a securities purchase agreement for a $1,000,000 private placement of 666,667 units at $1.50 per unit. While the termination itself is the stated Item 1.02 event, the material substance is the failure of a planned dilutive equity issuance that would have raised significant capital. For a small-cap company like Firefly Neuroscience, the loss of this $1M financing is material to investor assessment of liquidity and capital structure, even though the agreement was terminated rather than completed.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:31:44.844384+00:00","company_name":"FIREFLY NEUROSCIENCE, INC.","ticker":"AIFF","filing_date":"2026-06-26"}]}